SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001347178-20-000003
Filing Date
2020-02-26
Accepted
2020-02-26 07:02:16
Documents
107
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vnda1231201910k.htm   iXBRL 10-K 2486469
2 EXHIBIT 23.1 vnda12312019ex231.htm EX-23.1 2533
3 EXHIBIT 31.1 vnda12312019ex311.htm EX-31.1 12934
4 EXHIBIT 31.2 vnda12312019ex312.htm EX-31.2 12708
5 EXHIBIT 32.1 vnda12312019ex321.htm EX-32.1 8748
11 fanapt.gif GRAPHIC 3959
12 hetlioz.gif GRAPHIC 4652
13 partiiitem5chart.jpg GRAPHIC 107152
14 researchanddevelopment.jpg GRAPHIC 90664
  Complete submission text file 0001347178-20-000003.txt   10918203

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vnda-20191231.xsd EX-101.SCH 70013
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vnda-20191231_cal.xml EX-101.CAL 120202
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vnda-20191231_def.xml EX-101.DEF 279661
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vnda-20191231_lab.xml EX-101.LAB 854624
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vnda-20191231_pre.xml EX-101.PRE 522903
88 EXTRACTED XBRL INSTANCE DOCUMENT vnda1231201910k_htm.xml XML 1859379
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34186 | Film No.: 20653273
SIC: 2834 Pharmaceutical Preparations